This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Today's Small-Cap Winners and Losers

II-VI (IIVI), a maker of optical components, rose sharply a day after its earnings beat Wall Street's third-quarter expectations. The company made $7.5 million, or 25 cents a share, up from $5.8 million, or 19 cents a share, a year ago. Revenue for the quarter increased 11% to $59.4 million. Two analysts were looking for earnings of 21 cents.

For the fourth quarter, II-VI forecast revenue of $61 million to $63 million and earnings of 24 cents to 28 cents a share. Full-year revenue should be $229 million to $231 million with earnings of 89 cents to 93 cents, II-VI said. Shares of II-VI were up $2.84, or 16.4%, to $20.18.

GoAmerica (GOAM), a provider of communications services for people who are deaf, hard-of-hearing or have speech disabilities, rocketed nearly 46% higher after the company's i711.com was chosen as the exclusive IP-based relay service for Nordia's California Relay Services contract.

Nordia, one of three state contract holders that provide relay services to California, previously offered its own IP relay service. Shares of GoAmerica were up $1.54 to $4.90.

North American Scientific (NASI) saw its shares jump following news that it received clearance from the Food and Drug Administration to market a brachytherapy product for breast cancer. Brachytherapy, or internal radiation therapy, uses radioactive sources or seeds to treat tumors. North American's stock was up 44 cents, or 20%, to $2.63.

Shares of Discovery Laboratories (DSCO) were getting hammered a day after the company said the U.S. regulatory approval process for Surfaxin, a product for preventing respiratory distress syndrome in premature infants, could be significantly delayed. The reason is that data on Surfaxin's stability weren't sufficient, and new test batches will probably have to be produced.

Because of the delay, Discovery is analyzing all aspects of its business with an immediate goal of conserving cash. Establishing "a commercial infrastructure" is no longer in its near-term plans, the company said. Shares of Discovery were sinking $2.36, or 50.3%, to $2.33.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs